| Ipilimumab |
477202-00-9 |
|
| Bevacizumab |
216974-75-3 |
|
| Infliximab |
170277-31-3 |
|
| Adalimumab |
331731-18-1 |
C6428H9912N1694O1987S46 |
| Cetuximab |
205923-56-4 |
C33H38N4O6.C20H23N7O7.C4H3N2O2F |
| Aflibercept |
845771-78-0 |
|
| Nivolumab |
946414-94-4 |
|
| Triarylsulfonium Hexafluoroantimonate Salts in Propylene Carbonate |
109037-75-4 |
C36H28S3+2.C24H19S2+.3[F6Sb-] |
| Cyclohex-2-enol |
822-67-3 |
C6H10O |
| 2,3,6,7,10,11-hexabromotriphenylene |
82632-80-2 |
C18H6Br6 |
| 2,6-Dibromoanthracene |
186517-01-1 |
C14H8Br2 |
| Pembrolizumab |
1374853-91-4 |
|
| Ethyl 1-benzyl-4,5-dioxopyrrolidine-3-carboxylate |
5336-50-5 |
C14H15NO4 |
| Methyl 5-bromopyrazine-2-carboxylate |
210037-58-4 |
C6H5N2O2Br |
| 4-Bromo-1-(n-propyl)imidazole |
1353856-52-6 |
C6H9N2Br |
| 1H-Imidazole, 2,4,5-tribromo-1-propyl- |
31250-78-9 |
C6H7N2Br3 |
| 4-Bromo-1-(iso-propyl)-1H-imidazole |
623577-60-6 |
C6H9N2Br |
| 4-Bromo-1-ethyl-1H-imidazole |
875340-91-3 |
C5H7N2Br |
| 1H-Imidazole, 2,4,5-tribromo-1-ethyl- |
31250-75-6 |
C5H5N2Br3 |
| Tert-butyl 3-((di-tert-butoxycarbonyl)amino)-5-(1-hydroxyethyl)-1H-pyrazole-1-carboxylate |
1439824-04-0 |
C20H33N3O7 |
